Acknowledgement
Supported by : Konkuk University Medical Center
References
- Attenberger UI, Runge VM, Jackson CB, Baumann S, Birkemeier K, Michaely HJ, et al. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T. Invest Radiol 2009;44:251-256 https://doi.org/10.1097/RLI.0b013e31819ba711
- Kim ES, Chang JH, Choi HS, Kim J, Lee SK. Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine. AJNR Am J Neuroradiol 2010;31:1055-1058 https://doi.org/10.3174/ajnr.A2010
- Healy ME, Hesselink JR, Press GA, Middleton MS. Increased detection of intracranial metastases with intravenous Gd- DTPA. Radiology 1987;165:619-624 https://doi.org/10.1148/radiology.165.3.3317496
- Byrne TN. Imaging of gliomas. Semin Oncol 1994;21:162-171
- Uysal E, Erturk SM, Yildirim H, Seleker F, Basak M. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. AJR Am J Roentgenol 2007;188:697-702 https://doi.org/10.2214/AJR.05.2212
- Maravilla KR, Maldjian JA, Schmalfuss IM, Kuhn MJ, Bowen BC, Wippold FJ 2nd, et al. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 2006;240:389-400 https://doi.org/10.1148/radiol.2402051266
- Jacobs AH, Kracht LW, Gossmann A, Ruger MA, Thomas AV, Thiel A, et al. Imaging in neurooncology. NeuroRx 2005;2:333-347 https://doi.org/10.1602/neurorx.2.2.333
- Suh CH, Kim HS, Choi YJ, Kim N, Kim SJ. Prediction of Pseudoprogression in Patients with Glioblastomas Using the Initial and Final Area Under the Curves Ratio Derived from Dynamic Contrast-Enhanced T1-Weighted Perfusion MR Imaging. AJNR Am J Neuroradiol 2013;34:2278-2286 https://doi.org/10.3174/ajnr.A3634
- Furutani K, Harada M, Mawlan M, Nishitani H. Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging. J Comput Assist Tomogr 2008;32:313-319 https://doi.org/10.1097/RCT.0b013e318074fd9d
- Moon WJ. Measurement of signal-to-noise ratio in MR imaging with sensitivity encoding. Radiology 2007;243:908-909 https://doi.org/10.1148/radiol.2433060996
- Anzalone N, Gerevini S, Scotti R, Vezzulli P, Picozzi P. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine. Acta Radiol 2009;50:933-940 https://doi.org/10.1080/02841850903095385
- Benner T, Reimer P, Erb G, Schuierer G, Heiland S, Fischer C, et al. Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a doubleblinded randomized dose-finding study. J Magn Reson Imaging 2000;12:371-380 https://doi.org/10.1002/1522-2586(200009)12:3<371::AID-JMRI1>3.0.CO;2-3
- Knopp MV, Runge VM, Essig M, Hartman M, Jansen O, Kirchin MA, et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2004;230:55-64 https://doi.org/10.1148/radiol.2301021085
- Yuh WT, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 1995;16:373-380
- Barrett T, Brechbiel M, Bernardo M, Choyke PL. MRI of tumor angiogenesis. J Magn Reson Imaging 2007;26:235-249 https://doi.org/10.1002/jmri.20991
- Ocak I, Baluk P, Barrett T, McDonald DM, Choyke P. The biologic basis of in vivo angiogenesis imaging. Front Biosci 2007;12:3601-3616 https://doi.org/10.2741/2337
- Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110 https://doi.org/10.1148/radiology.211.1.r99ap38101
- Kramer H, Runge VM, Naul LG, Loynachan AT, Reiser MF, Wintersperger BJ. Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine. AJR Am J Roentgenol 2010;194:1337-1342 https://doi.org/10.2214/AJR.09.3427
Cited by
- Importance of Contrast-Enhanced Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging in Various Intracranial Pathologic Conditions vol.17, pp.1, 2014, https://doi.org/10.3348/kjr.2016.17.1.127
- Contrast-enhanced synthetic MRI for the detection of brain metastases vol.5, pp.2, 2014, https://doi.org/10.1177/2058460115626757
- Added Value of Arterial Spin-Labeling MR Imaging for the Differentiation of Cerebellar Hemangioblastoma from Metastasis vol.38, pp.11, 2014, https://doi.org/10.3174/ajnr.a5363
- Application of Synthetic MRI for Direct Measurement of Magnetic Resonance Relaxation Time and Tumor Volume at Multiple Time Points after Contrast Administration: Preliminary Results in Patients with B vol.19, pp.4, 2014, https://doi.org/10.3348/kjr.2018.19.4.783
- Time-Dependent Changes in the Magnetic Resonance Detection of Brain Metastases Using Single-Dose Gadobutrol vol.15, pp.1, 2014, https://doi.org/10.5812/iranjradiol.66054
- Sensitivity of different MRI sequences in the early detection of melanoma brain metastases vol.13, pp.3, 2014, https://doi.org/10.1371/journal.pone.0193946
- Does Multiphasic Contrast Enhanced Fluid Attenuated Inversion Recovery Magnetic Resonance Imaging Enhance the Detectability of Small Intracerebral Metastases? vol.78, pp.3, 2018, https://doi.org/10.3348/jksr.2018.78.3.179
- Effect of Gadolinium on the Estimation of Myelin and Brain Tissue Volumes Based on Quantitative Synthetic MRI vol.40, pp.2, 2014, https://doi.org/10.3174/ajnr.a5921
- Does an immobilization mask have added value during planning magnetic resonance imaging for stereotactic radiotherapy of brain tumours? vol.13, pp.None, 2020, https://doi.org/10.1016/j.phro.2020.02.003
- The value of DTI: achieving high diagnostic performance for brain metastasis vol.126, pp.2, 2014, https://doi.org/10.1007/s11547-020-01243-6